{"id":"W4399736408","doi":"10.1200/jco.2024.42.16_suppl.4090","title":"Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing biliary tract cancer (BTC) and pancreatic cancer (PC): Outcomes from DESTINY-PanTumor02 (DP-02).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Biliary tract cancer; Trastuzumab; Pancreatic cancer; Biliary tract; Internal medicine; Cancer; Oncology; Gemcitabine; Hepatocellular cancer; Gastroenterology; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007611209,0.0004241746,0.0005150641,0.0002142729,0.0001491042,0.000451415,0.0002311729,0.0003202876,0.0009639229],"category_scores_gemma":[0.0005999134,0.000191171,0.0005765886,0.0003291979,0.0003224107,0.000346718,0.0003052153,0.000651887,0.0001711717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007890369,"about_ca_system_score_gemma":0.000493359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00139743,"about_ca_topic_score_gemma":0.003442753,"domain_scores_codex":[0.999774,0.0001098933,0.00001683463,0.0000373184,0.0000244002,0.00003749374],"domain_scores_gemma":[0.9996978,0.00005300187,0.00009473562,0.00001821863,0.00001192534,0.0001243131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6063927,0.01493031,0.2274104,0.0004640025,0.002130301,0.0005070691,0.0003610152,0.003457801,0.02155638,0.0001585164,0.002213354,0.1204182],"study_design_scores_gemma":[0.1187667,0.3895686,0.4715335,0.00007605473,0.002150263,0.001539099,0.0002788402,0.004533101,0.005960192,0.0002869342,0.005263904,0.00004282087],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990476,0.0004676786,0.00003312501,0.00004188696,0.000005867282,0.00004813679,0.0001361248,0.000003786505,0.0002158282],"genre_scores_gemma":[0.9987643,0.0002560914,0.0001102391,0.00008273825,0.00001732562,0.0000398886,0.000439874,0.000001724464,0.0002878676],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00139743,"threshold_uncertainty_score":0.005724847,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0882904112290206,"score_gpt":0.4252072724073897,"score_spread":0.3369168611783691,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}